道明光學(002632.SZ):公司銀行賬户部分資金992.58萬元被凍結
格隆匯5月27日丨道明光學(002632.SZ)公佈,截至本公告日,公司銀行賬户部分資金992.580155萬元被凍結,佔公司最近一期經審計淨資產的0.51%。公司尚未收到法院相關法律文書,公司後續會根據相關規定及時披露該事項進展情況。本次部分資金凍結不會對公司日常經營和業務正常開展造成不利影響,也不會對公司業績產生重大的不利影響,但可能會對公司訴曹雯鈞、曹慧芳等人股權回購合同糾紛案件中的執行金額產生一定的不利影響。同時,公司將積極與法院、申請執行人進行溝通協商,依法保護公司的合法權益,履行責任義務,會盡快消除部分資金被凍結的風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.